EX1 Share Price History
24 Feb, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
29 Jan, 2020
The first human dosing of PlexarisTM has occurred in Exopharm’s PLEXOVAL Study.
19 Dec, 2019
A leading developer of exosome therapies, Australia-based Exopharm Limited, supports the US Food & Drug Administration (FDA) in highlighting the health dangers of unapproved products peddled by clinics that are openly flouting the rules.
25 Oct, 2019
If you want to know who really controls Exopharm Limited (ASX:EX1), then you'll have to look at the makeup of its...